T1 Energy's $135M purchase of formerly licensed TOPCon IP could save $25M-$40M in annual fees and improve future margins. A waiver to import up to 1.725 GW of cells could bridge Dallas production until G2 Austin starts in Q1 2027. It could be one of the energy sector's most interesting turnarounds, but is not proven: $120M in convertible debt has been raised, more funding is needed, and further debt or equity could limit existing shareholders' upside. x.com 

T1 Energy's Q2 results answered a short report that had questioned its Q1 cell sourcing. Revenue of $250M beat estimates by $47M, adjusted EBITDA turned positive, and G1 Dallas production was guided to the high end of 3.1-4.2 GW. Clearway signed a 641 MW offtake using domestic cells from the G2 Austin plant that starts up in Q1 2027, and Section 232 polysilicon tariffs take effect in December. It remains the most speculative name on the list, 63% off its high. x.com 

T1 Energy's new trade protection is real, but everything else cuts the other way. Section 232 price floors from December 4, 2026 make US wafers scarce, and T1 pre-bought polysilicon and wafers from Hemlock and Corning, yet its first domestic cell comes only in Q1 2027 and Phase 1 capex rose 20% to $510M as data centers bid up Texas labor. Q2 adjusted EBITDA of $10.7M was -$13.7M without a $24.4M tariff refund, and first-half free cash flow of -$264.8M against $79.1M of cash means more financing. … Show more

T1 Energy's G2_Austin buildout is a sign of life, but financing its costly first phase remains a major risk. The company estimates more than $500 million in total capex for its 2.1 GW Phase 1. Backup financing is likely to bring significant dilution; without funding, bankruptcy and an asset sale or dilution toward zero and a reverse split are likely. The price looks very interesting and the setup asymmetric, though downside remains significant. x.com  x.com 

T1 Energy's cell-import waiver keeps its Dallas module plant running while the Austin cell fab is built. Commerce permitted imports of up to 1.725 GW; Austin's first 2.1 GW phase targets cell production in Q4 2026. Street consensus is Moderate Buy with a $7.60 average target, roughly 3x from here. The chart marks $2.60 as the trigger, with targets of $3.93, $4.54, $5.13 and $5.92. x.com  x.com 

T1 Energy is a capital-structure story before a solar story. Its Q2 adjusted EBITDA turned positive only because a one-time tariff refund was moved into a metric guided to exclude it. Modules went only to related parties, giving no independent read on price. SG&A now exceeds gross profit, cash burn soared, inventory ballooned, and the Austin cell fab slipped a quarter as its budget rose. The ramp and policy tailwind are real, but a funded Phase 1 and a third-party customer come first. x.com 

T1 Energy is building one of America's largest solar fabs, targeting up to 5.3 GW of annual solar cell capacity, and is worth adding to between $6 and $8. x.com 

T1 Energy holds a named, near-term catalyst the market has not yet priced: financing for its G2 project is committed for Q2 2026, within six weeks. It is one of the only publicly traded US solar manufacturers operating at scale. It is a 1.1% position in Leopold Aschenbrenner's 13F; there, the large positions look priced for confirmation and were trimmed, while small positions with concrete pending events are where remaining asymmetry is more likely to sit. x.com 

T1 Energy is likely to struggle until financing terms are announced, though its long-term potential still justifies holding. x.com 

T1 Energy's existing sales and Clearway contract give its domestic solar buildout commercial footing as US policy pushes to cut reliance on foreign suppliers. It reported $250M in Q2 sales and a 641MW Clearway agreement, with first cells from its 2.1GW Austin factory expected in Q1 2027. Its Norway site also has approval for a planned 50MW data center as electricity demand rises. x.com  x.com